Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kiniksa Pharmaceuticals L...

    NASDAQ: KNSA · Real-Time Price · USD
    28.96
    0.52 (1.83%)
    At close: Jun 23, 2025, 11:38 AM

    Kiniksa Pharmaceuticals Statistics

    Share Statistics

    Kiniksa Pharmaceuticals has 72.97M shares outstanding. The number of shares has increased by 2.4% in one year.

    Shares Outstanding

    n/a
    		 72.97M

    Shares Change (YoY)

    n/a
    		 2.4%

    Shares Change (QoQ)

    n/a
    		 0.61%

    Owned by Institutions (%)

    n/a
    		 54.66%

    Shares Floating

    n/a
    		 69.73M

    Failed to Deliver (FTD) Shares

    n/a
    		 33,792

    FTD / Avg. Volume

    n/a
    		 5.16%

    Short Selling Information

    The latest short interest is 2.72M, so 3.72% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.72M

    Short % of Shares Out

    n/a
    		 3.72%

    Short % of Float

    n/a
    		 6.98%

    Short Ratio (days to cover)

    n/a
    		 5.46

    Valuation Ratios

    The PE ratio is -32.71 and the forward PE ratio is 21.99. Kiniksa Pharmaceuticals's PEG ratio is 0.08.

    PE Ratio

    n/a
    		 -32.71

    Forward PE

    n/a
    		 21.99

    PS Ratio

    n/a
    		 3.34

    Forward PS

    n/a
    		 1.8

    PB Ratio

    n/a
    		 3.22

    P/FCF Ratio

    n/a
    		 55.59

    PEG Ratio

    n/a
    		 0.08
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Kiniksa Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.3, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 3.3

    Quick Ratio

    n/a
    		 3.04

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.22

    Debt / FCF

    n/a
    		 0.39

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,343,615.87

    Profits Per Employee

    n/a
    		 $-137,120.63

    Employee Count

    n/a
    		 315

    Asset Turnover

    n/a
    		 0.73

    Inventory Turnover

    n/a
    		 2.31

    Taxes

    Income Tax

    n/a
    		 7.04M

    Effective Tax Rate

    n/a
    		 -19.48%

    Stock Price Statistics

    The stock price has increased by 52.77% in the last 52 weeks. The beta is 0.05, so Kiniksa Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.05

    52-Week Price Change

    n/a
    		 52.77%

    50-Day Moving Average

    n/a
    		 25.65

    200-Day Moving Average

    n/a
    		 23.01

    Relative Strength Index (RSI)

    n/a
    		 55.24

    Average Volume (20 Days)

    n/a
    		 655,233

    Income Statement

    In the last 12 months, Kiniksa Pharmaceuticals had revenue of 423.24M and earned -43.19M in profits. Earnings per share was -0.6.

    Revenue

    n/a
    		 423.24M

    Gross Profit

    n/a
    		 362.33M

    Operating Income

    n/a
    		 -45.62M

    Net Income

    n/a
    		 -43.19M

    EBITDA

    n/a
    		 -45.62M

    EBIT

    n/a
    		 -45.62M

    Earnings Per Share (EPS)

    n/a
    		 -0.6
    Full Income Statement

    Balance Sheet

    The company has 183.58M in cash and 9.86M in debt, giving a net cash position of 173.73M.

    Cash & Cash Equivalents

    n/a
    		 183.58M

    Total Debt

    n/a
    		 9.86M

    Net Cash

    n/a
    		 173.73M

    Retained Earnings

    n/a
    		 -521.14M

    Total Assets

    n/a
    		 599.33M

    Working Capital

    n/a
    		 258.64M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 25.69M and capital expenditures -277K, giving a free cash flow of 25.41M.

    Operating Cash Flow

    n/a
    		 25.69M

    Capital Expenditures

    n/a
    		 -277K

    Free Cash Flow

    n/a
    		 25.41M

    FCF Per Share

    n/a
    		 0.36
    Full Cash Flow Statement

    Margins

    Gross margin is 85.61%, with operating and profit margins of -10.78% and -10.21%.

    Gross Margin

    n/a
    		 85.61%

    Operating Margin

    n/a
    		 -10.78%

    Pretax Margin

    n/a
    		 -8.54%

    Profit Margin

    n/a
    		 -10.21%

    EBITDA Margin

    n/a
    		 -10.78%

    EBIT Margin

    n/a
    		 -10.78%

    FCF Margin

    n/a
    		 6%

    Dividends & Yields

    KNSA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for KNSA is $40, which is 40.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $40

    Price Target Difference

    n/a
    		 40.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 8.55

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist